OA
TARO

OFI Advisors’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

OFI Advisors’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-238
Closed -$35K – 1723
2014
Q4 		$35K Buy
+238
New +$35K ﹤0.01% 1624
2014
Q3 		– Sell
-28
Closed -$4K – 1732
2014
Q2 		$4K Buy
+28
New +$3.11K ﹤0.01% 1696

Other funds holding TARO

ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
GCM
Greywolf Capital Management Purchase, New York $67.3M AUM 100.05% 1-Year Est. Return
RCM
Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TI
Think Investments San Francisco, California $762M AUM 33.1% 1-Year Est. Return
AIM
Assured Investment Management New York $79.5M AUM 115.55% 1-Year Est. Return

OFI Advisors's TARO Position: Q1 2015 in Review

OFI Advisors sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q1 2015, closing a stake of 238 shares — an estimated $35K sold.

OFI Advisors first reported a position in TARO in Q2 2014 and held it in 2 quarters. The position peaked at $35K in Q4 2014. 96 funds tracked by Wall St. Rank hold TARO as of Q1 2015.

  • OFI Advisors reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q1 2015 after selling out during the quarter.
  • OFI Advisors sold 238 Taro Pharmaceutical Industries Ltd. shares in Q1 2015, an estimated $35K.
  • OFI Advisors first reported a position in Taro Pharmaceutical Industries Ltd. in Q2 2014 and held it in 2 quarters.
  • OFI Advisors's Taro Pharmaceutical Industries Ltd. position peaked at $35K in Q4 2014.
  • 96 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q1 2015.

Based on OFI Advisors's 13F filing for Q1 2015, filed 15 May 2015.